PWE-047 Improved patient-reported outcomes with upadacitinib over 52 weeks in patients with moderate-to-severe crohn’s disease
Posters | May 8, 2020 | Volume: No volume available | Issue: No issue available | Pages: A195.1-A195
10.1136/gutjnl-2019-bsgabstracts.371